Reuters logo
Express Scripts sees no let up in drug pricing chatter
December 14, 2016 / 3:26 PM / a year ago

Express Scripts sees no let up in drug pricing chatter

Dec 14 (Reuters) - Express Scripts Holding Co, the largest pharmacy benefit manager in the United States, said the conversation about drug pricing isn’t going away, about a week after President-elect Donald Trump vowed to bring down prices.

Shares of the company, which also signaled it was engaged in M&A discussions, were down 4 percent at $70.10 on Wednesday.

“It’s so early ... I’ve not seen anything that causes me to be hugely concerned,” said Chief Executive Tim Wentworth, in response to a question about the impact of the Trump administration on the industry on a call with analysts. (Reporting by Natalie Grover in Bengaluru; Editing by Saumyadeb Chakrabarty)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below